Indivior PLC Logo

Indivior PLC

Develops pharmaceuticals for opioid use disorder, addiction, and serious mental illnesses.

INDV | IL

Overview

Corporate Details

ISIN(s):
GB00BN4HT335 (+1 more)
LEI:
213800V3NCQTY7IED471
Country:
United Kingdom
Address:
234 BATH ROAD, SL1 4EE SLOUGH
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Indivior PLC is a global pharmaceutical company that develops, manufactures, and sells medicines to treat substance use disorders (SUD) and serious mental illnesses. The company's core focus is on pioneering treatments for opioid use disorder (OUD), with a portfolio centered on buprenorphine-based prescription pharmaceuticals. Indivior's research and development activities are concentrated on addressing addiction and behavioral health challenges. Originally a division of Reckitt Benckiser, the company was demerged to become an independent entity in December 2014.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-07-24 16:52
Major Shareholding Notification
Holding(s) in Company
English 23.4 KB
2025-07-24 09:34
Major Shareholding Notification
Holding(s) in Company
English 25.1 KB
2025-07-23 09:08
Major Shareholding Notification
Holding(s) in Company
English 25.1 KB
2025-07-21 17:23
Major Shareholding Notification
Holding(s) in Company
English 25.1 KB
2025-07-21 09:33
Major Shareholding Notification
Holding(s) in Company
English 25.1 KB
2025-07-18 09:35
Major Shareholding Notification
Holding(s) in Company
English 25.2 KB
2025-07-17 15:00
Report Publication Announcement
Notice of Results
English 10.6 KB
2025-07-01 09:43
Major Shareholding Notification
Holding(s) in Company
English 56.2 KB
2025-07-01 08:49
Declaration of Voting Results & Voting Rights Announcements
Total Voting Rights
English 4.8 KB
2025-06-30 08:00
Regulatory News Service
Indivior Announces Inclusion in US Russell Indexes
English 12.9 KB
2025-06-25 08:00
Board/Management Information
Indivior Appoints Tony Kingsley to the Board
English 14.0 KB
2025-06-17 17:42
Major Shareholding Notification
Holding(s) in Company
English 26.7 KB
2025-06-13 09:10
Director's Dealing
Director/PDMR Shareholding - Correction
English 28.2 KB
2025-06-12 17:24
Director's Dealing
Director/PDMR Shareholding
English 26.9 KB
2025-06-10 17:12
Major Shareholding Notification
Holding(s) in Company
English 26.8 KB

Automate Your Workflow. Get a real-time feed of all Indivior PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Indivior PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden 2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
Abliva Logo
Develops clinical-stage medicines for rare primary mitochondrial diseases to restore cell function.
Sweden ABLI
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
Access Bio, Inc. Logo
Develops and manufactures rapid diagnostic tests for infectious diseases for global health.
United States of America 950130
Active Biotech Logo
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
Sweden ACTI

Talk to a Data Expert

Have a question? We'll get back to you promptly.